Highlight
Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s Laboratories Ltd has entered into a licence agreement with Shanghai Henlius Biotech Inc for the development and commercialisation of the Chinese player’s investigational daratumumab biosimilar candidate HLX15.